Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Lebrikizumab in Pruritus: NCT07006792 Clinical Landscape Report 2026
16 October 2026
NCT07006792 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Netakimab in Plaque psoriasis: NCT07008547 Clinical Landscape Report 2026
16 October 2026
NCT07008547 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Delgocitinib in Pustulosis of Palms and Soles: NCT07013201 Clinical Landscape Report 2026
16 October 2026
NCT07013201 clinical landscape for Pustulosis of Palms and Soles: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Histamine Dihydrochloride in Pruritus: NCT07017231 Clinical Landscape Report 2026
16 October 2026
NCT07017231 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bosakitug in Eczema: NCT07011706 Clinical Landscape Report 2026
16 October 2026
NCT07011706 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IBI-3002 in Dermatitis, Atopic: NCT07015762 Clinical Landscape Report 2026
16 October 2026
NCT07015762 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
![[²²⁵Ac]Ac-AKY-1189 in Locally Advanced Malignant Solid Neoplasm: NCT07020117 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_03_d2c7dad0d6.jpg)
9 min read
[²²⁵Ac]Ac-AKY-1189 in Locally Advanced Malignant Solid Neoplasm: NCT07020117 Clinical Landscape Report 2026
16 October 2026
NCT07020117 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
INCB123667 in Platinum-Resistant Ovarian Carcinoma: NCT07023627 Clinical Landscape Report 2026
16 October 2026
NCT07023627 clinical landscape for Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
ASC50 in Plaque psoriasis: NCT07024602 Clinical Landscape Report 2026
16 October 2026
NCT07024602 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Ovarian Cancer: NCT07022535 Clinical Landscape Report 2026
16 October 2026
NCT07022535 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Primary peritoneal carcinoma: NCT07023484 Clinical Landscape Report 2026
16 October 2026
NCT07023484 clinical landscape for Primary peritoneal carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
UA-026 in Plaque psoriasis: NCT07038720 Clinical Landscape Report 2026
16 October 2026
NCT07038720 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.